论文信息 - Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response - 字舞流文

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Andreas Krause | H. Zeidler | G. Burmester | G. Burmester | A. Krause | J. Braun | J. Listing | H. Sörensen | J. Sieper | R. Alten | X. Baraliakos | M. Schneider | S. Schewe | X. Baraliakos | M. Schneider | C. Fritz | X. Baraliakos | J. Listing | Juergen Braun | J. Braun